These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 27451809)
1. Utility of Novel Plasma Metabolic Markers in the Diagnosis of Pediatric Tuberculosis: A Classification and Regression Tree Analysis Approach. Sun L; Li JQ; Ren N; Qi H; Dong F; Xiao J; Xu F; Jiao WW; Shen C; Song WQ; Shen AD J Proteome Res; 2016 Sep; 15(9):3118-25. PubMed ID: 27451809 [TBL] [Abstract][Full Text] [Related]
2. Metabolomics specificity of tuberculosis plasma revealed by (1)H NMR spectroscopy. Zhou A; Ni J; Xu Z; Wang Y; Zhang H; Wu W; Lu S; Karakousis PC; Yao YF Tuberculosis (Edinb); 2015 May; 95(3):294-302. PubMed ID: 25736521 [TBL] [Abstract][Full Text] [Related]
3. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis. Lau SK; Lee KC; Curreem SO; Chow WN; To KK; Hung IF; Ho DT; Sridhar S; Li IW; Ding VS; Koo EW; Wong CF; Tam S; Lam CW; Yuen KY; Woo PC J Clin Microbiol; 2015 Dec; 53(12):3750-9. PubMed ID: 26378277 [TBL] [Abstract][Full Text] [Related]
4. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique. Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139 [TBL] [Abstract][Full Text] [Related]
5. Plasma metabolic biomarkers for discriminating individuals with alcohol use disorders from social drinkers and alcohol-naive subjects. Mostafa H; Amin AM; Teh CH; Murugaiyah VA; Arif NH; Ibrahim B J Subst Abuse Treat; 2017 Jun; 77():1-5. PubMed ID: 28476260 [TBL] [Abstract][Full Text] [Related]
6. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients. Zhou A; Ni J; Xu Z; Wang Y; Lu S; Sha W; Karakousis PC; Yao YF J Proteome Res; 2013 Oct; 12(10):4642-9. PubMed ID: 23980697 [TBL] [Abstract][Full Text] [Related]
7. Exploration of Lipid Metabolism Alterations in Children with Active Tuberculosis Using UHPLC-MS/MS. Sun B; Liu F; Yin Q; Jiang T; Fang M; Duan L; Quan S; Tian X; Shen A; Mi K; Sun L J Immunol Res; 2023; 2023():8111355. PubMed ID: 36815950 [TBL] [Abstract][Full Text] [Related]
8. Analysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: application in a pilot study to discriminate patients with tuberculosis. Feng S; Du YQ; Zhang L; Zhang L; Feng RR; Liu SY Chin Med J (Engl); 2015 Jan; 128(2):159-68. PubMed ID: 25591556 [TBL] [Abstract][Full Text] [Related]
9. (1)H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. Shin JH; Yang JY; Jeon BY; Yoon YJ; Cho SN; Kang YH; Ryu DH; Hwang GS J Proteome Res; 2011 May; 10(5):2238-47. PubMed ID: 21452902 [TBL] [Abstract][Full Text] [Related]
10. Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children. Dutta NK; Tornheim JA; Fukutani KF; Paradkar M; Tiburcio RT; Kinikar A; Valvi C; Kulkarni V; Pradhan N; Shivakumar SVBY; Kagal A; Gupte A; Gupte N; Mave V; Gupta A; Andrade BB; Karakousis PC Sci Rep; 2020 Nov; 10(1):19527. PubMed ID: 33177551 [TBL] [Abstract][Full Text] [Related]
11. l-Histidine, arachidonic acid, biliverdin, and l-cysteine-glutathione disulfide as potential biomarkers for cured pulmonary tuberculosis. Yi WJ; Han YS; Wei LL; Shi LY; Huang H; Jiang TT; Li ZB; Chen J; Hu YT; Tu HH; Li JC Biomed Pharmacother; 2019 Aug; 116():108980. PubMed ID: 31125821 [TBL] [Abstract][Full Text] [Related]
12. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling. Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214 [TBL] [Abstract][Full Text] [Related]
13. High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans. Collins JM; Walker DI; Jones DP; Tukvadze N; Liu KH; Tran VT; Uppal K; Frediani JK; Easley KA; Shenvi N; Khadka M; Ortlund EA; Kempker RR; Blumberg HM; Ziegler TR PLoS One; 2018; 13(10):e0205398. PubMed ID: 30308073 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis. Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899 [TBL] [Abstract][Full Text] [Related]
15. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis. Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772 [TBL] [Abstract][Full Text] [Related]
16. Urinary metabolomic analysis to identify potential markers for the diagnosis of tuberculosis and latent tuberculosis. Deng J; Liu L; Yang Q; Wei C; Zhang H; Xin H; Pan S; Liu Z; Wang D; Liu B; Gao L; Liu R; Pang Y; Chen X; Zheng J; Jin Q Arch Biochem Biophys; 2021 Jun; 704():108876. PubMed ID: 33864753 [TBL] [Abstract][Full Text] [Related]
17. Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker. Izquierdo-Garcia JL; Comella-Del-Barrio P; Campos-Olivas R; Villar-Hernández R; Prat-Aymerich C; De Souza-Galvão ML; Jiménez-Fuentes MA; Ruiz-Manzano J; Stojanovic Z; González A; Serra-Vidal M; García-García E; Muriel-Moreno B; Millet JP; Molina-Pinargote I; Casas X; Santiago J; Sabriá F; Martos C; Herzmann C; Ruiz-Cabello J; Domínguez J Sci Rep; 2020 Dec; 10(1):22317. PubMed ID: 33339845 [TBL] [Abstract][Full Text] [Related]